IndexIQ Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-604
Closed -$56K 1585
2021
Q4
$56K Sell
604
-82
-12% -$5.4K ﹤0.01% 1120
2021
Q3
$41K Buy
686
+135
+25% +$7.97K ﹤0.01% 1107
2021
Q2
$38K Buy
551
+169
+44% +$11K ﹤0.01% 1094
2021
Q1
$27K Buy
+382
New +$29.4K ﹤0.01% 1105

IndexIQ Advisors's ARNA Position: Q1 2022 in Review

IndexIQ Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 604 shares — an estimated $56K sold.

IndexIQ Advisors first reported a position in ARNA in Q1 2021 and held it in 4 quarters. The position peaked at $56K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • IndexIQ Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 604 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $56K.
  • IndexIQ Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Arena Pharmaceuticals Inc position peaked at $56K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.